AFYA
Afya Limited NASDAQ Listed Jul 19, 2019$13.90
Mkt Cap $1.3B
52w Low $13.00
13.0% of range
52w High $19.90
50d MA $14.54
200d MA $14.77
P/E (TTM)
1.7x
EV/EBITDA
8.1x
P/B
0.3x
Debt/Equity
0.6x
ROE
—
P/FCF
7.4x
RSI (14)
—
ATR (14)
—
Beta
0.51
50d MA
$14.54
200d MA
$14.77
Avg Volume
103.7K
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Alameda Oscar Niemeyer, No. 119 · Nova Lima, MG · BR
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | AMC | 0.38 | 0.41 | +7.9% | 13.50 | +0.0% | +1.9% | +5.9% | +5.9% | +5.6% | +9.8% | — |
| Nov 12, 2025 | AMC | 0.32 | 0.38 | +18.8% | 14.45 | +0.7% | +1.4% | +2.7% | +0.2% | +2.2% | +2.6% | — |
| Aug 13, 2025 | AMC | 0.40 | 0.40 | +0.0% | 14.92 | +0.1% | +3.4% | +0.9% | +2.2% | +0.2% | +0.3% | — |
| May 8, 2025 | AMC | 0.46 | 0.55 | +19.6% | 19.40 | -2.1% | +1.1% | +0.2% | -0.9% | -2.1% | -0.3% | — |
| Mar 13, 2025 | AMC | 0.34 | 0.36 | +5.9% | 16.22 | +10.4% | +11.2% | +10.7% | +11.0% | +11.0% | +10.9% | — |
| Nov 13, 2024 | AMC | 0.36 | 0.32 | -11.1% | 17.30 | -1.0% | -6.6% | -7.5% | -5.0% | -6.0% | -5.4% | — |
| Aug 15, 2024 | AMC | 0.37 | 0.44 | +18.9% | 18.92 | -1.8% | -3.5% | -1.8% | -2.4% | -2.4% | -4.0% | — |
| May 9, 2024 | AMC | 0.47 | 0.55 | +17.0% | 18.18 | +5.3% | +0.5% | +1.7% | +2.6% | +4.7% | +5.3% | — |
| Mar 14, 2024 | AMC | 0.34 | 0.36 | +5.9% | 20.29 | +0.4% | +6.4% | +6.9% | +5.3% | +5.0% | +4.1% | — |
| Nov 13, 2023 | AMC | 0.31 | 0.28 | -9.7% | 17.60 | -1.4% | +2.4% | +5.9% | +4.2% | +7.6% | +10.2% | — |
| Aug 28, 2023 | AMC | 0.33 | 0.29 | -12.1% | 14.66 | -0.3% | +3.1% | +4.4% | +2.8% | +8.9% | +8.1% | — |
| May 24, 2023 | AMC | 0.39 | 0.34 | -12.8% | 11.85 | +1.3% | +7.2% | +6.8% | +1.9% | -1.0% | -0.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 | BofA Securities | Downgrade | Buy → Neutral | — | $13.93 | $13.67 | -1.9% | -0.5% | -2.0% | -2.7% | -2.4% | -3.7% |
| Feb 13 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $14.49 | $14.11 | -2.6% | -2.9% | -3.9% | -3.7% | -3.5% | -2.7% |
| Jan 16 | UBS | Downgrade | Buy → Neutral | — | $14.39 | $13.81 | -4.0% | -3.2% | -5.1% | -2.9% | -0.5% | +1.8% |
| Jan 8 | UBS | Maintains | Buy → Buy | — | $14.80 | $14.73 | -0.5% | +0.1% | +1.6% | +2.6% | +0.1% | -1.6% |
| Jan 7 | JP Morgan | Downgrade | Overweight → Neutral | — | $15.51 | $14.81 | -4.5% | -4.6% | -4.5% | -3.0% | -2.1% | -4.4% |
| Sep 8 | JP Morgan | Upgrade | Neutral → Overweight | — | $15.04 | $16.16 | +7.4% | +3.8% | +3.5% | +1.0% | +4.5% | +3.7% |
| Sep 8 | UBS | Upgrade | Neutral → Buy | — | $15.04 | $16.16 | +7.4% | +3.8% | +3.5% | +1.0% | +4.5% | +3.7% |
| Jul 29 | Citigroup | Upgrade | Sell → Neutral | — | $13.83 | $14.24 | +3.0% | +2.5% | +0.7% | -0.9% | -1.1% | +3.1% |
| Jun 12 | UBS | Maintains | Neutral → Neutral | — | $17.99 | $18.00 | +0.1% | +0.0% | +0.7% | +1.7% | +2.8% | +1.9% |
| Mar 11 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $16.97 | $16.08 | -5.2% | -6.4% | -4.8% | -4.4% | +6.2% | +5.8% |
| Jan 31 | Citigroup | Downgrade | Neutral → Sell | — | $16.84 | $15.96 | -5.2% | -4.1% | -4.1% | -2.2% | -5.6% | -1.0% |
| Jan 17 | JP Morgan | Maintains | Neutral → Neutral | — | $15.65 | $15.66 | +0.1% | +0.6% | +0.1% | +0.6% | +1.2% | +4.6% |
| Jun 21 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $16.61 | $16.48 | -0.8% | +0.2% | +1.1% | +0.9% | +3.0% | +4.3% |
| Jan 22 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $22.37 | $21.78 | -2.6% | -9.8% | -8.5% | -9.5% | -7.8% | -9.2% |
| Nov 27 | JP Morgan | Downgrade | Overweight → Neutral | — | $20.33 | $19.62 | -3.5% | -0.5% | -0.5% | +1.1% | +0.6% | +0.6% |
| Oct 13 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $15.43 | $15.99 | +3.6% | -0.2% | +2.6% | +2.4% | +0.2% | +0.3% |
| Nov 22 | Credit Suisse | Maintains | Outperform → Outperform | — | $15.79 | $15.61 | -1.1% | -7.6% | -2.8% | -6.8% | -7.7% | -7.5% |
| Aug 23 | Credit Suisse | Upgrade | Neutral → Outperform | — | $12.40 | $13.23 | +6.7% | +2.4% | +6.3% | +6.7% | +3.2% | +5.0% |
| Apr 8 | Credit Suisse | Upgrade | Neutral → Outperform | — | $14.52 | $15.52 | +6.9% | +5.8% | -4.8% | -10.5% | -7.6% | -4.6% |
| Mar 7 | UBS | Maintains | Buy → Buy | — | $11.87 | $12.82 | +8.0% | -1.2% | +3.3% | +9.7% | +10.5% | +5.1% |
| Jul 21 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $25.20 | $24.73 | -1.9% | -4.0% | -5.6% | -7.8% | -9.8% | -9.2% |
| Apr 15 | UBS | Upgrade | Neutral → Buy | — | $21.53 | $22.45 | +4.3% | +7.0% | +10.6% | +9.6% | +7.3% | +4.5% |
| Feb 4 | JP Morgan | Upgrade | Neutral → Overweight | — | $22.92 | $25.73 | +12.3% | +3.7% | +8.4% | +3.8% | +4.1% | +3.4% |
| Oct 19 | JP Morgan | Downgrade | Overweight → Neutral | — | $26.86 | $25.56 | -4.8% | -7.4% | -6.2% | -5.1% | -6.0% | -1.8% |
| Sep 28 | Goldman Sachs | Upgrade | Neutral → Buy | — | $25.95 | $27.50 | +6.0% | +4.0% | +3.6% | +5.0% | +3.8% | +2.9% |
| Sep 15 | BofA Securities | Maintains | Buy → Buy | — | $26.16 | $26.64 | +1.8% | +1.7% | -2.8% | -6.5% | -8.8% | -6.8% |
| Aug 19 | Credit Suisse | Maintains | Neutral → Neutral | — | $24.96 | $24.73 | -0.9% | +0.3% | -1.2% | -2.1% | -3.4% | -3.0% |
| May 20 | UBS | Downgrade | Buy → Neutral | — | $19.50 | $17.81 | -8.7% | -9.4% | -8.2% | -12.9% | -11.5% | -7.4% |
| May 5 | JP Morgan | Maintains | Overweight → Overweight | — | $20.84 | $21.06 | +1.1% | -0.8% | +3.0% | -0.7% | +2.7% | +3.7% |
| Mar 9 | JP Morgan | Maintains | Overweight → Overweight | — | $23.15 | $22.19 | -4.1% | -7.6% | -7.6% | -18.2% | -26.7% | -17.8% |
| Jan 15 | UBS | Maintains | Buy → Buy | — | $27.30 | $28.41 | +4.1% | +3.6% | +4.0% | +5.3% | +6.7% | +6.3% |
| Sep 19 | UBS | Maintains | Buy → Buy | — | $22.97 | $23.42 | +2.0% | +4.6% | +3.0% | +0.4% | -1.5% | -0.4% |
| Aug 13 | Morgan Stanley | Maintains | Overweight → Overweight | — | $25.09 | $24.77 | -1.3% | -0.1% | -2.6% | -0.4% | +2.0% | +7.7% |
| Aug 13 | Bank of America | Maintains | Buy → Buy | — | $25.09 | $24.77 | -1.3% | -0.1% | -2.6% | -0.4% | +2.0% | +7.7% |
| Aug 13 | Goldman Sachs | Maintains | Neutral → Neutral | — | $25.09 | $24.77 | -1.3% | -0.1% | -2.6% | -0.4% | +2.0% | +7.7% |
| Aug 9 | JP Morgan | Maintains | Overweight → Overweight | — | $25.48 | $25.71 | +0.9% | -2.2% | -1.5% | -1.6% | -4.0% | -1.9% |
No insider trades available.
No recent filings available.
Data updated apr 24, 2026 4:27pm
· Source: massive.com